Cargando…

Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis

OBJECTIVES: Imaging of joint inflammation provides a standard against which to derive an updated DAS for RA. Our objectives were to develop and validate a DAS based on reweighting the DAS28 components to maximize association with US-assessed synovitis. METHODS: Early RA patients from two observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Hensor, Elizabeth M A, McKeigue, Paul, Ling, Stephanie F, Colombo, Marco, Barrett, Jennifer H, Nam, Jackie L, Freeston, Jane, Buch, Maya H, Spiliopoulou, Athina, Agakov, Felix, Kelly, Stephen, Lewis, Myles J, Verstappen, Suzanne M M, MacGregor, Alexander J, Viatte, Sebastien, Barton, Anne, Pitzalis, Costantino, Emery, Paul, Conaghan, Philip G, Morgan, Ann W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649844/
https://www.ncbi.nlm.nih.gov/pubmed/30824919
http://dx.doi.org/10.1093/rheumatology/kez049
_version_ 1783438060790218752
author Hensor, Elizabeth M A
McKeigue, Paul
Ling, Stephanie F
Colombo, Marco
Barrett, Jennifer H
Nam, Jackie L
Freeston, Jane
Buch, Maya H
Spiliopoulou, Athina
Agakov, Felix
Kelly, Stephen
Lewis, Myles J
Verstappen, Suzanne M M
MacGregor, Alexander J
Viatte, Sebastien
Barton, Anne
Pitzalis, Costantino
Emery, Paul
Conaghan, Philip G
Morgan, Ann W
author_facet Hensor, Elizabeth M A
McKeigue, Paul
Ling, Stephanie F
Colombo, Marco
Barrett, Jennifer H
Nam, Jackie L
Freeston, Jane
Buch, Maya H
Spiliopoulou, Athina
Agakov, Felix
Kelly, Stephen
Lewis, Myles J
Verstappen, Suzanne M M
MacGregor, Alexander J
Viatte, Sebastien
Barton, Anne
Pitzalis, Costantino
Emery, Paul
Conaghan, Philip G
Morgan, Ann W
author_sort Hensor, Elizabeth M A
collection PubMed
description OBJECTIVES: Imaging of joint inflammation provides a standard against which to derive an updated DAS for RA. Our objectives were to develop and validate a DAS based on reweighting the DAS28 components to maximize association with US-assessed synovitis. METHODS: Early RA patients from two observational cohorts (n = 434 and n = 117) and a clinical trial (n = 59) were assessed at intervals up to 104 weeks from baseline; all US scans were within 1 week of clinical exam. There were 899, 163 and 183 visits in each cohort. Associations of combined US grey scale and power Doppler scores (GSPD) with 28 tender joint count and 28 swollen joint count (SJC28), CRP, ESR and general health visual analogue scale were examined in linear mixed model regressions. Cross-validation evaluated model predictive ability. Coefficients learned from training data defined a re-weighted DAS28 that was validated against radiographic progression in independent data (3037 observations; 717 patients). RESULTS: Of the conventional DAS28 components only SJC28 and CRP were associated with GSPD in all three development cohorts. A two-component model including SJC28 and CRP outperformed a four-component model (R(2) = 0.235, 0.392, 0.380 vs 0.232, 0.380, 0.375, respectively). The re-weighted two-component DAS28CRP outperformed conventional DAS28 definitions in predicting GSPD (Δtest log-likelihood <−2.6, P < 0.01), Larsen score and presence of erosions. CONCLUSION: A score based on SJC28 and CRP alone demonstrated stronger associations with synovitis and radiographic progression than the original DAS28 and should be considered in research on pathophysiological manifestations of early RA. Implications for clinical management of RA remain to be established.
format Online
Article
Text
id pubmed-6649844
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-66498442019-07-29 Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis Hensor, Elizabeth M A McKeigue, Paul Ling, Stephanie F Colombo, Marco Barrett, Jennifer H Nam, Jackie L Freeston, Jane Buch, Maya H Spiliopoulou, Athina Agakov, Felix Kelly, Stephen Lewis, Myles J Verstappen, Suzanne M M MacGregor, Alexander J Viatte, Sebastien Barton, Anne Pitzalis, Costantino Emery, Paul Conaghan, Philip G Morgan, Ann W Rheumatology (Oxford) Clinical Science OBJECTIVES: Imaging of joint inflammation provides a standard against which to derive an updated DAS for RA. Our objectives were to develop and validate a DAS based on reweighting the DAS28 components to maximize association with US-assessed synovitis. METHODS: Early RA patients from two observational cohorts (n = 434 and n = 117) and a clinical trial (n = 59) were assessed at intervals up to 104 weeks from baseline; all US scans were within 1 week of clinical exam. There were 899, 163 and 183 visits in each cohort. Associations of combined US grey scale and power Doppler scores (GSPD) with 28 tender joint count and 28 swollen joint count (SJC28), CRP, ESR and general health visual analogue scale were examined in linear mixed model regressions. Cross-validation evaluated model predictive ability. Coefficients learned from training data defined a re-weighted DAS28 that was validated against radiographic progression in independent data (3037 observations; 717 patients). RESULTS: Of the conventional DAS28 components only SJC28 and CRP were associated with GSPD in all three development cohorts. A two-component model including SJC28 and CRP outperformed a four-component model (R(2) = 0.235, 0.392, 0.380 vs 0.232, 0.380, 0.375, respectively). The re-weighted two-component DAS28CRP outperformed conventional DAS28 definitions in predicting GSPD (Δtest log-likelihood <−2.6, P < 0.01), Larsen score and presence of erosions. CONCLUSION: A score based on SJC28 and CRP alone demonstrated stronger associations with synovitis and radiographic progression than the original DAS28 and should be considered in research on pathophysiological manifestations of early RA. Implications for clinical management of RA remain to be established. Oxford University Press 2019-08 2019-03-01 /pmc/articles/PMC6649844/ /pubmed/30824919 http://dx.doi.org/10.1093/rheumatology/kez049 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Science
Hensor, Elizabeth M A
McKeigue, Paul
Ling, Stephanie F
Colombo, Marco
Barrett, Jennifer H
Nam, Jackie L
Freeston, Jane
Buch, Maya H
Spiliopoulou, Athina
Agakov, Felix
Kelly, Stephen
Lewis, Myles J
Verstappen, Suzanne M M
MacGregor, Alexander J
Viatte, Sebastien
Barton, Anne
Pitzalis, Costantino
Emery, Paul
Conaghan, Philip G
Morgan, Ann W
Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis
title Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis
title_full Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis
title_fullStr Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis
title_full_unstemmed Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis
title_short Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis
title_sort validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649844/
https://www.ncbi.nlm.nih.gov/pubmed/30824919
http://dx.doi.org/10.1093/rheumatology/kez049
work_keys_str_mv AT hensorelizabethma validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT mckeiguepaul validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT lingstephanief validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT colombomarco validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT barrettjenniferh validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT namjackiel validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT freestonjane validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT buchmayah validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT spiliopoulouathina validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT agakovfelix validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT kellystephen validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT lewismylesj validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT verstappensuzannemm validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT macgregoralexanderj validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT viattesebastien validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT bartonanne validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT pitzaliscostantino validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT emerypaul validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT conaghanphilipg validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis
AT morganannw validityofatwocomponentimagingderiveddiseaseactivityscoreforimprovedassessmentofsynovitisinearlyrheumatoidarthritis